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Background: Blood loss during resection of the hepatic parenchyma in hepatectomy can be minimized
using vessel-sealing (VS) devices. Some sealing devices were retrospectively compared to evaluate the
efﬁcacy of each device for controlling blood loss, transection time and postoperative complications in
hepatectomy as a cohort study.
Methods: Between 2005 and September 2012, hepatectomy was underwent in 150 patients using one of
three types of LigaSure (Dolphin Tip Laparoscopic Instrument, Precise or Small Jaw) or the Harmonic
Focus or Ace ultrasonic dissecting sealer. Results were compared to crush-clamping alone as the control
method by the historical study (n ¼ 81).
Results: Irrespective of the vessel-sealing device used for underlying chronic hepatitis, blood loss, blood
transfusion rate, operating time and transection time were signiﬁcantly reduced in the VS group
compared with controls (p < 0.05). Rates of postoperative bile leakage and intra-abdominal abscess
formation were signiﬁcantly lower in the VS group than in controls (p < 0.05). Comparing devices,
LigaSure Small Jaw and Harmonic Focus showed lower blood loss, shorter transection time and reduced
rates of post-hepatectomy complications, in turn resulting in shorter hospital stays (p < 0.05). Tendencies
toward uncontrolled ascites and bile leakage were only concern with the use of Harmonic Focus.
Satisfactory surgical results were achieved using the sealing device for laparoscopic hepatectomy.
Conclusions: The use of energy sealing devices improves surgical results and avoids hepatectomy-related
complications. Adequate use of vessel sealers is necessary for safe and rapid completion of hepatic
resection.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Minimization of blood loss during hepatic parenchymal tran-
section remains a concern, despite recent advances in surgical
techniques and perioperative management for hepatic resection.1
The increased amount of blood loss and related transfusion are
risk factors for morbidity and mortality in patients who undergo
hepatectomy.2 The crush clamping method for hepatic paren-
chymal transection is well-known and widely applied, offering a
simple approach with ﬂexible control.3,4 We have used this tech-
nique for the past 15 years and, however, small remnant branches
must be tied using numerous knots, which may require a relatively
long time. To reduce operative risks, further improvements in
surgical techniques and/or hemostatic devices are needed for he-
patic transection in patients with both normal and diseased livers.5: þ81 95 819 7306.
nashima).
ciates Ltd. Published by Elsevier LtThe latest surgical devices for hemostasis have been applied in liver
surgery in recent years.5e9 Kristinn et al. recently reported that the
LigaSure, using powerful bipolar electric thermal energy, is more
efﬁcient than ultrasonic shears for hepatic resection in a porcine
model.7 To overcome the limitations of the classical crush clamping
method, we have begun to apply a combination technique with
vessel-sealing devices in hepatic resection since 2008. We have
already provided a preliminary report of the usefulness of such a
combination method using the LigaSure Precise, a prototype de-
vice offering reductions in blood loss, transection time and risk of
morbidity.10 Over the past several years, the utility of vessel-sealing
devices used at our institute has changed.We hypothesized that the
operative record should be improved by using the powerful and fast
hemostatic devices. However, no full comparisons of each method
have yet been reported, and the clinical advantages and disad-
vantages of each method need to be clariﬁed.
To this end, the present cohort study retrospectively examined
patient demographics, surgical records and patient outcomes,d. All rights reserved.
Table 1
Shape and function of LigaSure products and harmonic scalpels.
Seal length
(mm)
Seal width
(mm)
Cut length
(mm)
Used situation
LigaSure V 18e19.5 4.6e5 12e17.8 Laparoscopic use
LigaSure Precise 16.5 3 Nil Open use for narrow
part
LigaSure Small Jaw 16.5 4 14.7 Open use for narrow
part
Harmonic Focus 16 1.4 16 Open use for narrow
part
Harmonic Ace 12 1.4 12 Laparoscopic use
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various type of LigaSure vessel-sealing device and an ultrasonic
coagulator system in patients who underwent hepatectomy in
recent years.
2. Materials and methods
2.1. Patients
We retrospectively and historically examined 267 patients with liver disease
who underwent hepatic resection in our institute between 2005 and September
2012. The present cohort setting compared patient demographics, parameters of
preoperative liver function, background liver status, surgical records and post-
operative course according to the extent of hepatectomy between conventional
crush clamping (control group, treated between 2004 and 2008; n ¼ 118) and vessel
sealing (VS group, treated between 2008 and 2012; n¼ 149). All patients’ in-hospital
data was consecutively collected during these follow-up periods. There were no
patient selection or matching criteria, and all patients were enrolled for the present
study. Informed consent for data collection and use of hemostatic devices was ob-
tained from each patient prior to enrollment. The study design was approved by the
ethics review board at our institution. Data were retrieved from both anesthetic and
patient charts by the NUGSBS database.
2.2. Operative procedures
In the case of open laparotomy, the procedure included routine clamping of the
hepatoduodenal ligament to occlude total inﬂow to the liver during transection. It
also included the use of the forceps crush clamping method4 and an ultrasonic
dissector (USU MH-207; Olympus, Tokyo, Japan) around the major vessels. Using a
Kelly clamp, the hepatic parenchyma was gently crushed and conﬁrmation was
obtained that the remnant vessels and tiny vessels (2 mm in diameter) were
divided by the vessel sealers.10,11 Larger vessels (3mm in diameter) were tied using
absorbable braid (Ethicon, Somerville, NJ). Glissonian branches near the secondary
trunk were also tied. The isolated large hepatic vein was ligated by Endopath-
Endocutter ETS-Frex 35 (staple load; 3.0  35 mm, white cartilage; Ethicon Endo-
surgery, Johnson & Johnson Company, Somerville, NJ).12
The present series used three types of LigaSure system (Surgical Solutions
Group, Boulder, CO): LigaSure Precise Instrument (LS1200); LigaSure Small Jaw
Instrument (LF1212); and LigaSure Dolphin Tip Laparoscopic Instrument (LS1500).
Characteristics of blade size, style, sealed width and length are compared in Fig. 1
and Table 1. LigaSure V was used for both open and laparoscopic procedures. With
LigaSure Precise Instrument, sealed vessels were cut using ﬁne scissors by the ﬁrst
assistant operator.10,13,14 The other two devices had a built-in cutting function. The
power supply level was ﬁxed at level 2. The LigaSure vessel-sealing generator was
the new ForceTriad Energy platform, which includes a hand and foot switchFig. 1. Comparison of function between three types of LigaSure system, LigaSure Precis
Dolphin Tip Laparoscopic Instrument (LS1500). Comparison of function of the ultrasonic c
Shears as a laparoscopic instrument were also compared.(Valleylab), as a full-featured radiofrequency energy system allowing precise auto-
matic management of energy and desired tissue effect in Fig. 2.
Other types of vessel sealer were Harmonic Focus Curved Shears (ultrasonic
coagulator dissector; Ethicon Endo-surgery) for open laparotomy11 and Harmonic
Ace Curved Shears (Ethicon Endo-surgery) for laparoscopic hepatectomy.15e17
Coagulation and dissecting power is equivalent to Harmonic Focus and Ace. Char-
acteristics of blade size, style, sealed width and length are compared in Fig. 1 and
Table 1. This device includes an automatic cutting function during coagulation. The
power supply level was ﬁxed within the range of 3e5. A Harmonic Device Generator
300 system was operated using a hand switch (Ethicon Endo-surgery), as a full-
featured high-frequency mechanical energy system. The sealing time is again only
a few seconds, providing fast, powerful sealing in Fig. 2.17
Decisions onwhich instrument to use for open laparotomy were made based on
the judgment of the operator during the period of the present study (Operator A.N.,
T.A. and S.T.), which was a potential bias in the present study. The vessel sealer was
clamped along the hepatic vein and sealed the branched veins without clipping or
ligation.10 Any bleeding site and macroscopically detected bile leakage points in the
cut plane were sutured using absorbable 4-0 monoﬁlament polydioxanone (PDS)-II
suture (Ethicon).
In the present study, the patient demographics, surgical records and post-
operative outcomes after hepatectomy were compared between the control group
without vessel sealers and the vessel sealer group. Furthermore, the vessel sealer
group was subdivided by the groups of each vessel sealing instrument. Such a
clinical parameter was often examined to clarify the usefulness of surgical devices.2.3. Statistical analysis
All continuous data are expressed as mean  standard deviation. Data of
different groups were compared using one-way analysis of variance. The c2 test was
used for comparisons of categorical variables. Differences between groups weree Instrument (LS1200); LigaSure Small Jaw Instrument (LF1212); and LigaSure
oagulators; Harmonic Focus Curved Shears for open use and Harmonic Ace Curved
Fig. 2. Generators of energy devices.
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the most sensitive analysis. A two-tailed P value of less than 0.05 was considered
signiﬁcant. SPSS Statistics version 18 software (IBM, Armonk, NY) was used in all
statistical analyses.
3. Results
3.1. Patient data
The control group (n ¼ 118) underwent limited resection in 38
patients (32%), segmentectomy or sectionectomy in 43 (21%),
hemihepatectomy or more extensive resection in 31 (36%), central
bisegmentectomy in 1 (1%) and trisegmentectomy in 5 (10%). Child-
Pugh classiﬁcation was A in 112 patients (95%) and B in 6. In the VS
group (n ¼ 149), limited resection was performed in 56 patients
(including laparoscopic limited resection in 15), segmentectomy or
sectionectomy in 45 (including laparoscopic lateral segmentectomy
in 6), hemihepatectomy or more extensive resection in 42 (36%),
central bisegmentectomy in 3 (1%) and trisegmentectomy in 2 (10%).
Child-Pugh classiﬁcationwas A in 147 patients (99%) and B in 2. We
compared data between the two groups according to the extent of
hepatectomy as: 1) smaller hepatectomy than sectionectomy (81
patients in the control group; 81 patients in the VS group, including
LigaSure V in 5 patients, LigaSure Precise in 36, LigaSure Small Jaw in
30 and Harmonic Focus in 10); 2) hemihepatectomy or more
extensive resection (37 patients in the control group; 47 patients in
the VS group, including LigaSure Precise in 21, LigaSure Small Jaw in
12 and Harmonic Focus in 14); and 3) laparoscopic or laparoscopy-
assisted hepatectomy using VS in 21 patients (including LigaSure V
in 11 patients, LigaSure Precise in 5, and Harmonic Ace in 5).
3.2. Surgical records
Table 2 shows the clinical data of patients who underwent
smaller hepatectomy. The prevalence of chronic viral hepatitis was
signiﬁcantly greater in the VS group (35%) than in the control group
(15%) (p < 0.05). The prevalence of hepatocellular carcinoma (HCC)
tended to be greater in the VS group (48%) than in the control group(37%), but no signiﬁcant difference was identiﬁed. Operative blood
loss and use of red cell transfusion were signiﬁcantly less frequent
in the VS group than in the control group (p< 0.01). Total operating
time and hepatic parenchymal transection time were signiﬁcantly
shorter in the VS group than in the control group (p < 0.05). The
prevalence of bile leakage was signiﬁcantly lower in the VS group
than in the control group (p < 0.05), while the prevalence that of
associated intra-abdominal infection tended to be lower in the VS
group than in the control group, although no signiﬁcant difference
was evident. The duration of hospitalization was signiﬁcantly
shorter in the VS group than in the control group (p < 0.01). Patient
demographics, liver function, surgical records, post-hepatectomy
morbidity and duration of hospitalization did not differ signiﬁ-
cantly between each device.
Table 3 shows the clinical data of patients who underwent major
hepatectomy. Prevalence of obstructive jaundice or biliary tract
carcinomas tended to be greater in the VS group that in the control
group, but no signiﬁcant difference was apparent. Operative blood
loss and blood transfusion were signiﬁcantly lower in the VS group
than in the control group (p < 0.05). Hepatic parenchymal transec-
tion time tended to be shorter in the VS group than in the control
group, but no signiﬁcant difference was seen. The prevalence of
uncontrolled ascites was signiﬁcantly lower in the VS group than in
the control group (p < 0.05). The duration of hospitalization was
signiﬁcantly shorter in the VS group than in the control group
(p < 0.01). Patient demographics and liver function did not differ
signiﬁcantly between devices. Operative blood loss was signiﬁcantly
lower in the LigaSure Precise and Small Jaw groups than in the
Harmonic group (p< 0.05). Hepatic parenchymal transection time in
the LigaSure Small Jaw group was signiﬁcantly lower than those in
the LigaSure Precise group and the control group (p < 0.05). The
prevalence of uncontrolled ascites was signiﬁcantly higher in the
Harmonic group than in other groups (p < 0.05). Prevalence of bile
leakage and intra-abdominal infection were signiﬁcantly lower in
the LigaSure Precise group than in other groups. Duration of hospi-
talizationwas signiﬁcantly shorter in the LigaSure Precise group than
in the Harmonic group (p < 0.05).
Table 2
Comparison of data from the control group and vessel-sealer groups for patients who underwent limited resection, segmentectomy or sectionectomy.
Control group
(n ¼ 81)
VS group
(n ¼ 81)
p Value LigaSure V
(n ¼ 5)
LigaSure precise
(n ¼ 36)
LigaSure small
jaw (n ¼ 30)
Harmonic
UC (n ¼ 10)
p Value
Age (years) 66  12 67  12 .344 667  13 67  13 65  12 71  6 .339
Gender (male/female) 58/23 56/25 .742 3/2 24/12 23/7 5/5
Background liver condition
Normal/chronic hepatitis/cirrhosis/jaundice 54/12/14/1 41/28/12/0 .0002 4/0/1/0 15/14/7/0 16/13/1/0 7/1/2/0 .243
Liver disease
HCC/ICC/liver metastasis/BC/Others 30/1/38/7/5 39/6/27/7/2 .084 1/1/3/0/0 21/1/11/1/2 14/2/12/2/0 2/2/1/4/1 .670
Preoperative liver function
ICGR15 (%) 14.6  9.3 15.5  10.6 .762 13.5  10.6 14.5  9.1 14.6  9.3 19.8  7.8
Surgical records
Blood loss (ml) 1040  984 613  544 .0004 520  99 703  619 560  474 534  445 .647
Red cell transfusion rate (No/Yes) 60/21 75/6 .0007 4/1 31/5 30/0 10/0
Total operation time (minutes) 418  144 346  122 .0016 294  79 345  113 345  128 371  144
Transection time (minutes) 56  20 43  28 .045 48  22 58  33 45  17 31  28
Outcome
Hospital death (No/Yes) 80/1 80/1 1.0 5/0 36/0 29/1 10/0 .665
Hepatectomy-related complications (No/Yes) 73/8 69/12 .419 4/1 27/9 28/2 10/0 .105
Uncontrolled ascitesa (No/Yes) 74/7 70/11 .403 4/1 28/8 28/2 10/0 .126
Bile leakage (No/Yes) 71/10 79/2 .029 5/0 35/1 30/0 9/1 .319
Intraabdominal abscess formation (No/Yes) 73/8 79/2 .080 5/0 36/0 28/2 10/0 .350
Hospital stay (days) 24  12 16  12 <.0001 15  11 18  17 14  6 19  9
Continuous data are mean  SD or categorical data are number of patients.
UC; ultrasonic coagulator, ICGR15: Indocyanine green retention rate at 15 min, HCC: hepatocellular carcinoma.
ICC: intrahepatic cholangiocellular carcinoma, BC: biliary tract carcinoma.
a After 1-week of treatment with diuretics.
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laparoscopic minor hepatectomy. Patient demographics and liver
function did not differ between groups. In the VS group, operative
blood loss tended to be lower than in the control group, although
no signiﬁcant difference was seen. Hepatic parenchymal transec-
tion time was signiﬁcantly shorter in the VS group than in the
control group (p< 0.05). Post-hepatectomy complications were not
observed in all patients, and no signiﬁcant difference in prevalence
was identiﬁed between VS and control groups. The duration of
hospitalizationwas signiﬁcantly shorter in the VS group than in the
control group (p < 0.01). HCC was not observed in the Harmonic
group, but was seen in other LigaSure groups (p < 0.05). Operative
blood loss tended to be lower in the LigaSure Precise group than inTable 3
Comparison of data from the control group and vessel-sealer groups for patients who un
Control group
(n ¼ 37)
VS group
(n ¼ 47)
Age (years) 68  11 67  14
Gender (male/female) 24/13 30/12
Background liver condition
Normal/chronic hepatitis/cirrhosis/jaundice 21/13/2/1 20/13/2/12
Liver disease
HCC/ICC/liver metastasis/BC/Others 14/8/5/7/3 12/8/5/16/6
Preoperative liver function
ICGR15 (%) 13.2  8.8 12.2  5.8
Surgical records
Blood loss (ml) 2093  1458 924  723
Red cell transfusion rate (No/Yes) 18/19 35/12
Total operation time (minutes) 656  202 587  192
Transection time (minutes) 47  19 43  17
Outcome
Hospital death (No/Yes) 35/2 46/1
Hepatectomy-related complications (No/Yes) 29/8 33/14
Uncontrolled ascites* (No/Yes) 30/7 45/2
Bile leakage (No/Yes) 32/5 42/5
Intraabdominal abscess formation (No/Yes) 30/7 41/6
Hospital stay (days) 36  23 24  13
For abbreviations, see Table 2.
*; p < 0.05 vs. the Harmonic group.
#; p < 0.05 vs. the LigaSure Precise group.
yp < 0.05 vs. the Harmonic UC group.other groups, but no signiﬁcant difference was apparent. Total
operation time was signiﬁcantly lower in the LigaSure Precise
group than in the LigaSure V group (p < 0.05) and hepatic paren-
chymal transection time was signiﬁcantly shorter in the LigaSure
Precise group than in the Harmonic (Ace) group (p < 0.05). Post-
hepatectomy complications were not observed in all patients who
underwent laparoscopic hepatectomy.
4. Discussion
The LigaSure system comprises various instruments for open
and laparoscopic use (http://www.ligasure.com/ligasure/pages.
aspx?page¼Products)13,14,16,18,19 and the Harmonic system alsoderwent hemihepatectomy or more extended hepatectomy.
p Value LigaSure
precise (n ¼ 21)
LigaSure small
jaw (n ¼ 12)
Harmonic
UC (n ¼ 14)
p Value
.414 68  11 71  9 64  20 .670
.671 12/9 8/4 10/4
.082 7/9/1/4 6/3/0/3 7/1/1/5 .381
.078 8/2/1/7/3 3/4/1/3/1 1/2/3/6/2 .349
.803 12.0  6.0 12.9  6.4 11.8  5.2
.0054 1029  637* 952  567* 1410  1010 .703
.032 15/6 7/5 10/4
.169 575  180 623  157 578  241
.055 44  23 40  8# 42  10
.580 21/0 12/0 13/1 .299
.552 19/2 8/4 6/8 .010
.039 19/2 10/2 6/8 .0048
.911 21/0 10/2 10/4 .041
.638 21/0 9/3 11/3 .060
.0096 19  6y 24  18 27  12
Table 4
Comparison of data from the control group and vessel-sealer groups for patients who underwent laparoscopic limited resection and lateral segmentectomy.
Control group
(n ¼ 81)
Laparo VS group
(n ¼ 21)
p Value LigaSure V
(n ¼ 11)
LigaSure
precise (n ¼ 5)
Harmonic
UC (n ¼ 5)
p Value
Age (years) 66  12 64  11 .414 65  11 67  13 58  9 .170
Gender (male/female) 58/23 14/7 .671 7/4 3/2 5/0
Background liver condition
Normal/chronic hepatitis/cirrhosis/jaundice 54/12/14/1 14/2/5/0 .082 5/2/4/0 4/0/1/0 5/0/0/0 .280
Liver disease
HCC/ICC/liver metastasis/BC/Others 30/1/38/7/5 9/0/11/0/1 .078 7/0/4/0/0 2/0/2/0/1 0/0/5/0/0 .004
Preoperative liver function
ICGR15 (%) 14.6  9.3 13.9  7.5 .803 14.1  8.3 14.2  9.9 13.3  3.1
Hepatectomy
Limited resection/Lateral segmentectomy 38/5 15/6 .327 7/4 4/1 4/1 .269
Surgical records
Blood loss (ml) 1040  984 279  430 .0054 470  512 35  27 59  48 .408
Red cell transfusion rate (No/Yes) 54/27 36/12 .032 9/2 5/0 5/0
Total operation time (minutes) 418  144 300  173 .169 387  178 163  78* 231  106
Transection time (minutes) 56  20 27  21 .055 43  37 16  2** 51  38
Outcome
Hospital death (No/Yes) 80/1 21/0 .580 11/0 5/0 5/0 1.0
Hepatectomy-related complications (No/Yes) 73/8 21/0 .552 11/0 5/0 5/0 1.0
Uncontrolled ascites* (No/Yes) 74/7 21/0 .039 11/0 5/0 5/0 1.0
Bile leakage (No/Yes) 71/10 21/0 .911 11/0 5/0 5/0 1.0
Intraabdominal abscess formation (No/Yes) 73/8 21/0 .638 11/0 5/0 5/0 1.0
Hospital stay (days) 24  12 13  7 .0096 17  11 9  3 7  1
For abbreviations, see Table 2.
*p < 0.05 vs. the LigaSure V group.
**p < 0.01 vs. the Harmonic UC group.
Fig. 3. Cut surface of parenchymal transections by A) LigaSure and B) Harmonic.
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healthcare-products/recent).6,11,15,16 Since our preliminary report
regarding the efﬁcacy of the LigaSure Precise for hepatic resec-
tion,10 the new LigaSure Small Jaw and Harmonic Focus devices
have been developed.11 We have therefore been using various de-
vices for hepatectomy, as in the present study. Other powerful in-
struments such as advanced diathermy devices, bipolar
coagulators, the TissueLink dissecting sealer and so on have been
recently been released worldwide.4,9,20e22 We regret that ran-
domized selection of devices could not be performed in the present
series, which might thus be inﬂuenced by some selection bias. Each
device used in the present study offered powerful sealing activ-
ity,10,11,16,19 but the length or width of the blades did not always
match the narrow spaces encountered during hepatic parenchymal
transection. The shape of the area between the handle and blade of
the LigaSure and Harmonic coagulator resembles a small for-
ceps,11,17 offering high grasping ability and various grip positions
that are feasible in a wide range of situations. Since the thermal
range around the grasping blade is quite limited within 1e2 mm,
thermal damage to the deep cut surface of the liver can be avoi-
ded.16 (Fig. 3) Based on the forceps-like conﬁguration, the tip of the
blade is easy to widely palpate compared with other instruments
designed with a long shaft for laparoscopic use. Compared to the
LigaSure device, an ultrasonic dissector may produce more heat
damage.6,16 Kim et al. reported a signiﬁcant increase in bile leakage
when using the ultrasonic dissector,23 although another study
showed no major postoperative complications.6,11 The differences
creating advantages or disadvantages for each device must there-
fore be clariﬁed to achieve reliable, safe hepatic transection.
In the present study, blood loss and related need for red cell
transfusion, the time required for transection of the hepatic pa-
renchyma and related operating time were shorter in the VS group
than in controls, as expected from the pilot study10 and other
reports.8,11,13e15,18,19 Nevertheless, at smaller hepatectomy series,
the prevalence of underlying chronic hepatitis was higher in the
VS group and differences in the above-mentioned parameters
were signiﬁcantly better in the VS group. The usefulness of VS has
thus been highlighted. Although crush clamping was oftendifﬁcult in cirrhotic liver, hard ﬁbrotic tissues could be sufﬁciently
coagulated and cut simultaneously using high-energy devices.24,25
With respect to postoperative morbidity, VS could also prevent
bile leak and associated intra-abdominal infection. As a result, the
A. Nanashima et al. / International Journal of Surgery 11 (2013) 891e897896
ORIGINAL RESEARCHduration of hospitalization could be signiﬁcantly shortened in the
VS group due to better results for surgical data and morbidity As
bile leakage sometimes causes major problems leading to pro-
longed hospitalization,26 control of bile leakage using VS provides
a great many clinical beneﬁts. In the large hepatectomy series,
surgical records from the VS group were also better, even though
the prevalence of biliary tract carcinoma was higher in the VS
group. In the case of biliary carcinoma, more complicated hepa-
tectomies such as caudate lobe resection or combined vascular
resection and reconstruction were necessary, which might have
led to longer operating times and greater blood loss. However,
surgical records for patients with hilar bile duct carcinomas in the
VS group tended to be better than expected and the morbidity of
ascites from the lymphatic duct could be controlled using VS. As a
result, clinical beneﬁts with shorter duration of hospitalization
could be obtained along with successful minor hepatectomy in the
present series.
We examined surgical outcomes in patients who underwent
laparoscopic minor hepatectomy in this study. In cases of laparo-
scopic or laparoscopy-assisted hepatectomy with small incision
laparotomy, use of VS is always necessary.19,27,28 In the present
series, surgical outcomes were quite good, without any post-
hepatectomy complications and limited blood loss, as described
in other reports.27,28 The sealing capacity of energy devices would
be clariﬁed by these results as Pringle’s maneuver, as the in-ﬂow
occlusion technique was not applied in such cases.29
By comparison with each device, the forceps-style LigaSure for
open use was preferentially applied in our series, although the bias
of disease selection might not have been marked. The forceps-style
LigaSure showed better surgical records and patient outcomes in
patients who underwent major hepatectomy, although differences
in surgical records between each device were not observed in pa-
tients with minor hepatectomy. Production of uncontrolled ascites
and bile leakage by ultrasonic coagulators as Harmonic Focus or Ace
remained a concern, because such complications would result in a
longer hospital stay.23 In our experiences during hepatectomy, bile
leakage has often been seen in the transected cut plane. When we
noticed bile leakage intraoperatively, leakages could be repaired by
suture. Ultrasonic coagulating devices might allow faster cutting
with hemostasis due to high energy, but sealing the lymphatic duct
and bile duct would be insufﬁcient using fast speed sealing. Care
must be taken to carefully seal the parts of the lymphatic duct and
Glissonian pedicle when the ultrasonic coagulator was used. Small
Jaw showed the best surgical records and outcomes in general
because a cutting function was added. Although selection bias re-
mains, LigaSure Small Jaw would be recommended for use in open
hepatectomy in comparisonwith LigaSure Precise or V based on the
present results. By making comparisons with the latest forceps-
style devices, LigaSure Small Jaw and Harmonic Focus, we could
not clarify superiority between devices, as both utility and efﬁcacy
were similar. As described above, ascites and bile leakage after
hepatectomy were only concerns when using the Harmonic Focus.
To the best of our knowledge, such comparisons between devices
have yet to be reported.
In laparoscopic hepatectomy, LigaSure Precise tended to show
better surgical records in comparison with Harmonic group in the
present study. LigaSure Precise is basically an open use instrument,
and so was used for laparoscopy-assisted hepatectomy with mini-
mal incisions.30 The LigaSure V and Harmonic Ace were usually
used in laparoscopic hepatectomy,7,15,27,28 so we also clariﬁed
herein the usefulness of VS in our series. The present study was a
retrospectively cohort study, in which the present study design
might provide some bias in results. Therefore, it is necessary to
design a prospective randomized study in each subgroup in the
suture step.In conclusion, the latest vessel sealer is very useful for open and
laparoscopic hepatectomy for hepatic parenchymal transection in
comparison with the conventional procedure, due to the minimi-
zation of blood loss and the shortening of transection time,
resulting in better postoperative outcomes in hepatectomy. In
vessel sealers, the latest forceps-style devices are better suited to
open use. In laparoscopic hepatectomy, use of a vessel sealer is
essential and surgical outcomes are quite satisfactory.
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